To determine whether urinary EVs could be used to examine other genes associated with prostate cancer we investigated the differential expression of androgen receptor (AR), BIRC5, ERG, PCA3, TMPRSS2:ERG and TMPRSS2 in Bx Pos versus Bx Neg patients (Fig 3a). This evidence concerns the gene PCA3 and prostate carcinoma.